McCullough PA, Chan CT, Weinhandl ED, Burkart JM, Bakris GL

Slides:



Advertisements
Similar presentations
Cardiovascular Disease In CKD: Is It for Children
Advertisements

BEST: Beta-blocker Evaluation Survival Trial Purpose To determine whether the β-blocker bucindolol reduces morbidity and mortality in patients with advanced.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 6: Mortality.
Copland M, Komenda P, Weinhandl ED, McCullough PA, Morfin JA
Commentary on ‘The DOPPS Practice Monitor for US Dialysis Care: Potential Impact of Recent Guidelines and Regulatory Changes on Management of Mineral.
2016 Annual Data Report, Vol 2, ESRD, Ch 6
The SPRINT Research Group
Figure 10.1 Dialysis unit counts, by unit affiliation, 2011–2014
Intensive Hemodialysis, Treatment Complications and Tolerability
Copyright © 2011 American Medical Association. All rights reserved.
CORAL Trial design: Patients with renal artery stenosis and hypertension or chronic kidney disease were randomized to renal artery stenting (n = 467) vs.
Copyright © 2000 American Medical Association. All rights reserved.
Volume 2: End-Stage Renal Disease
Volume 2: End-Stage Renal Disease
Copyright © 2015 by the American Osteopathic Association.
Intensive Hemodialysis, Treatment Complications and Tolerability
McCullough PA, Chan CT, Weinhandl ED, Burkart JM, Bakris GL
2016 Annual Data Report, Vol 2, ESRD, Ch 4
Copland M, Komenda P, Weinhandl ED, McCullough PA, Morfin JA
Intensive Hemodialysis and Health-related Quality of Life
Intensive Hemodialysis and Health-related Quality of Life
Cardiac Arrhythmias in Dialysis Patients
Hypertension in Dialysis Patients
Intensive Hemodialysis and Potential Risks with Increasing Treatment
Adjusted relative mortality risk
Bakris GL, Burkhart JM, Weinhandl ED, McCullough PA, Kraus MA
Bakris GL, Burkhart JM, Weinhandl ED, McCullough PA, Kraus MA
In Reply to ‘The Importance of Icodextrin Use for Technique and Patient Survival in Peritoneal Dialysis’  Emily J. See, MBBS, David W. Johnson, PhD, Yeoungjee.
Hypertension in Dialysis Patients
Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical.
SIGNIFY Trial design: Participants with stable coronary artery disease without clinical heart failure and resting heart rate >70 bpm were randomized to.
Nat. Rev. Cardiol. doi: /nrcardio
The US Renal Data System “Pie Chart of Death”
Survival differences between peritoneal dialysis and hemodialysis among “large” ESRD patients in the United States  Austin G. Stack, Bhamidipati V.R.
Cardiovascular Disease and CKD: Core Curriculum 2010
Intensive Hemodialysis and Potential Risks with Increasing Treatment
Intensive Hemodialysis and Health-Related Quality of Life
The risk of hospitalization and modality failure with home dialysis
Insights From the 2016 Peer Kidney Care Initiative Report: Still a Ways to Go to Improve Care for Dialysis Patients  James B. Wetmore, Suying Li, Julia.
Smoking and cardiovascular outcomes in dialysis patients: The United States Renal Data System Wave 2 Study1,2  Robert N. Foley, Charles A. Herzog, Allan.
Chapter 3: Management of progression and complications of CKD
Volume 85, Issue 1, Pages (January 2014)
Coronary artery bypass grafting in diabetics: A growing health care cost crisis  Sajjad Raza, MD, Joseph F. Sabik, MD, Ponnuthurai Ainkaran, MS, Eugene.
Preoperative statin treatment is associated with reduced postoperative mortality and morbidity in patients undergoing cardiac surgery: An 8-year retrospective.
Volume 80, Issue 10, Pages (November 2011)
Vitality Measured as Self-reported Energy Level and Clinical Outcomes in Hemodialysis Patients: The Japanese Dialysis Outcomes and Practice Pattern Study.
Homocysteine and risk in end-stage renal disease: a matter of context
Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical.
Recasting Kidney Failure as Cardiovascular Disease
Michael Copland, MD, Paul Komenda, MD, Eric D
Volume 77, Issue 7, Pages (April 2010)
A decade after the Surgical Treatment for Ischemic Heart Failure (STICH) trial: Weaving firm clinical recommendations from lessons learned  Robert E.
Mortality, Hospitalization, and Technique Failure in Daily Home Hemodialysis and Matched Peritoneal Dialysis Patients: A Matched Cohort Study  Eric D.
Body size and outcomes on peritoneal dialysis in the United States
2013 Annual Report - 36th Edition
Jeffrey Perl, MD, FRCP(C), Christopher T. Chan, MD, FRCP(C) 
Dialysate Sodium: Choosing the Optimal Hemodialysis Bath
Volume 83, Issue 2, Pages (February 2013)
Peter A. McCullough, MD, MPH, Christopher T. Chan, MD, Eric D
Intensive Hemodialysis and Potential Risks With Increasing Treatment
George L. Bakris, MD, John M. Burkart, MD, Eric D
KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 Update of Hemoglobin Target    American.
Better Management of Volume with Intensive Hemodialysis
Volume 82, Issue 3, Pages (August 2012)
The Use of Vaccines in Adult Patients With Renal Disease
Commentary on ‘The DOPPS Practice Monitor for US Dialysis Care: Potential Impact of Recent Guidelines and Regulatory Changes on Management of Mineral.
American Journal of Kidney Diseases
Increase of physical activity over time associated with lower HF risk
American Journal of Kidney Diseases
Identification of thresholds for significant renal recovery in relation to patient and renal survival. Identification of thresholds for significant renal.
Presentation transcript:

Intensive Hemodialysis, Left Ventricular Hypertrophy and Cardiovascular Disease McCullough PA, Chan CT, Weinhandl ED, Burkart JM, Bakris GL. Intensive Hemodialysis, Left Ventricular Hypertrophy, and Cardiovascular Disease. American Journal of Kidney Diseases, Volume 68, Issue 5, S5 - S14. AdvancingDialysis.org

Risk of Hospitalization The long interdialytic interval, commonly referred to as the 2-day “Killer Gap,” is a time of heightened risk of mortality and morbidity with conventional hemodialysis.1 Rates of death and cardiovascular hospitalization were 23% and 124% higher after the gap, respectively, than on other days.1 Chapter 1, Figure 1: Rates of death and cardiovascular hospitalization on the day after the 2-day gap in dialysis treatment and on all others days.1 23% Risk of Death 124% Risk of Hospitalization 1Foley, R. N., Gilbertson, D. T., Murray, T., & Collins, A. J. (2011). Long interdialytic interval and mortality among patients receiving hemodialysis. New England Journal of Medicine, 365(12), 1099-1107. AdvancingDialysis.org

Cardiovascular-related deaths in prevalent dialysis patients are common.1 Over 41% of all deaths were cardiovascular-related, with nearly identical percentages in hemodialysis and peritoneal dialysis patients.1 Chapter 1, Figure 2: Distribution of primary cause of death in hemodialysis patients, 2011 to 2013.1 1Saran R, Li Y, Robinson B, et al. US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis Off J Natl Kidney Found. 2015;66(1 Suppl 1):Svii, S1-305. doi:10.1053/j.ajkd.2015.05.001 AdvancingDialysis.org

Multiple randomized clinical trials show intensive hemodialysis significantly reduces left ventricular mass.1,2,3 Chapter 1, Figure 3: Effects of intensive versus conventional hemodialysis on left ventricular mass in the FHN Daily Trial,1 the FHN Nocturnal Trial,2 and the Canadian trial of nocturnal hemodialysis.3 Estimated treatment effects (solid dots) and associated 95% confidence intervals (solid lines) are displayed at the bottom. 1FHN Trial Group, Chertow GM, Levin NW, et al. In-center hemodialysis six times per week versus three times per week. N Engl J Med. 2010;363(24):2287-2300. doi:10.1056/NEJMoa1001593. 2Rocco MV, Lockridge RS, Beck GJ, et al. The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int. 2011;80(10):1080-1091. doi:10.1038/ki.2011.213. 3Culleton BF, Walsh M, Klarenbach SW, et al. Effect of frequent nocturnal hemodialysis vs. conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA. 2007;298(11):1291-1299. doi:10.1001/jama.298.11.1291. -13.8 g -10.9 g -15.3 g AdvancingDialysis.org

Short daily hemodialysis was associated with lower risk of cardiovascular-related hospitalization, compared to conventional in-center hemodialysis.1 Short daily hemodialysis was associated with lower risks of hospitalization due to cerebrovascular disease, heart failure/fluid overload, and hypertensive disease.1 Chapter 1, Figure 4: Relative hazards of cause-specific cardiovascular hospitalization for short daily hemodialysis versus in-center hemodialysis1 and versus peritoneal dialysis.2 Solid lines represent 95% confidence intervals around estimated hazard ratios (solid dots). Abbreviations: CIHD, in-center hemodialysis; PD, peritoneal dialysis; SDHD, short daily hemodialysis. 1Weinhandl ED, Nieman KM, Gilbertson DT, Collins AJ. Hospitalization in daily home hemodialysis and matched thrice-weekly in-center hemodialysis patients. Am J Kidney Dis Off J Natl Kidney Found. 2015;65(1):98-108. doi:10.1053/j.ajkd.2014.06.015. 2Weinhandl ED, Gilbertson DT, Collins AJ. Mortality, Hospitalization, and Technique Failure in Daily Home Hemodialysis and Matched Peritoneal Dialysis Patients: A Matched Cohort Study. Am J Kidney Dis Off J Natl Kidney Found. 2016;67(1):98-110. doi:10.1053/j.ajkd.2015.07.014. AdvancingDialysis.org

Short daily hemodialysis was associated with lower risks of cardiovascular-related hospitalization, compared to peritoneal dialysis.1 Short daily hemodialysis was associated with lower risks of hospitalization due to cerebrovascular disease, heart failure/fluid overload, hypertensive and peripheral artery diseases.1 Chapter 1, Figure 4: Relative hazards of cause-specific cardiovascular hospitalization for short daily hemodialysis versus in-center hemodialysis2 and versus peritoneal dialysis.1 Solid lines represent 95% confidence intervals around estimated hazard ratios (solid dots). Abbreviations: CIHD, in-center hemodialysis; PD, peritoneal dialysis; SDHD, short daily hemodialysis. 1Weinhandl ED, Gilbertson DT, Collins AJ. Mortality, Hospitalization, and Technique Failure in Daily Home Hemodialysis and Matched Peritoneal Dialysis Patients: A Matched Cohort Study. Am J Kidney Dis Off J Natl Kidney Found. 2016;67(1):98-110. doi:10.1053/j.ajkd.2015.07.014. 2Weinhandl ED, Nieman KM, Gilbertson DT, Collins AJ. Hospitalization in daily home hemodialysis and matched thrice-weekly in-center hemodialysis patients. Am J Kidney Dis Off J Natl Kidney Found. 2015;65(1):98-108. doi:10.1053/j.ajkd.2014.06.015. AdvancingDialysis.org